about
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment. Its first asset, Plinabulin...
Read More
1.64
0.03
(1.86%)
22,900
XNAS Volume
XNAS 24 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
BeyondSpring Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..